New Technologies for Influenza Vaccines
Vaccine development has been hampered by the long lead times and the high cost required to reach the market. The 2020 pandemic, caused by a new coronavirus (SARS-CoV-2) that was first reported in late 2019, has seen unprecedented rapid activity to generate a vaccine, which belies the traditional vac...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2020-11-01
|
| coleção: | Microorganisms |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2076-2607/8/11/1745 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|